Geron Corporation operates as a biopharmaceutical company. The company supports the clinical stage development of imetelstat, a telomerase inhibitor for the treatment of hematologic myeloid malignancies. It has collaboration and license agreement with Janssen Biotech, Inc. to develop and commercialize imetelstat worldwide for indications in oncology, including hematologic myeloid malignancies and other human therapeutic uses. The company was founded in 1990 and is based in Menlo Park, California.
This stock seems to want to avoid going sub-$1 right now, looks like there's some possibility to show strength in the 1-hour chart If it gets going up, it could make $1.70 easy, but $2.50 looks like the most it could attain. Might be some fireworks in short term, but not looking like a long-term hold.
this is not consultation or advice. Gern: as long as the price below EMA(orange line) and the dots on the halfway indicator (blue line) are red, the target is the low target indicator and the trend is bearish.
this is not consultation or advice. All Indicator lines used as dynamic support and resistance, that change reliance on the price and time. When the price reach and meet one of the indicator, the trend stop, and new trend begin. the system show the next price target at high probability(no 100%). Gern: as long as the price above EMA(orange line) and above the halfway indicator (blue line), the trend is bullish.
this is not consultation or advice. All Indicator lines used as dynamic support and resistance, that change reliance on the price and time. When the price reach and meet one of the indicator, the trend stop, and new trend begin. the system show the next price target at high probability(no 100%). Gern: As long as the price below EMA(orange line) and below the halfway indicator (blue line), the trend is bearish.
